Novartis AG
COMBINATIONS OF FGFR4 INHIBITORS AND BILE ACID SEQUESTRANTS

Abstract:

The present invention relates to a pharmaceutical combination comprising an FGFR4 inhibitor and a bile acid sequestrant, to the use of the pharmaceutical combination in the treatment of cancer, to the use of a bile acid sequestrant to reduce or mitigate side-effects associated with FGFR4 inhibition therapy.